NCT07578376

Brief Summary

This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participants in the control condition will be invited to attend ER class after the 3-month observation period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
215

participants targeted

Target at P75+ for not_applicable

Timeline
48mo left

Started Jun 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2030

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

3.6 years

First QC Date

April 28, 2026

Last Update Submit

May 11, 2026

Conditions

Keywords

Empowered ReliefChronic PainCancer survivorSurvey StudyMonthly follow-upsZoom class

Outcome Measures

Primary Outcomes (1)

  • Overall treatment satisfaction

    0-10 scale, higher scores indicate greater satisfaction, mean should be 8 or higher

    Immediately after intervention

Secondary Outcomes (4)

  • Pain Intensity

    1 month after intervention

  • Pain Interference

    1 month after intervention

  • Pain Intensity

    3 months after intervention

  • Pain Interference

    3 months after intervention

Study Arms (2)

Empowered Relief

EXPERIMENTAL

Participants in this arm of the study will complete the one-time 2hr Empowered Relief zoom course. They will also complete a post-course survey as well as the standardized 1, 2, and 3-month follow-up surveys.

Behavioral: Empowered Relief Course (Zoom)

Wait-List Control

NO INTERVENTION

Participants in the Wait-List Control (WLC) arm will not have initial access to the empowered relief course. Additionally they will not have to complete a post-course survey. The WLC group will be asked to complete the 1, 2, and 3-month follow-up studies after no intervention. After this 3-month observatory period, WLC participants will have voluntary access to the Empowered Relief course.

Interventions

This is a one-time 2 hour long skills-based pain management class delivered by certified instructors. Participants learn three core pain relief skills, develop a personalized plan, and receive access to a free binaural audio app for daily use and supportive daily text messages.

Empowered Relief

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of cancer diagnosis, completion of active cancer treatment, cancer free at the time of enrollment, experience of body pain most or every day, pain duration at least 3 months, and English fluency.

You may not qualify if:

  • Significant psychological and cognitive impairment that limits one's ability to complete study tasks (completion of online survey, attending the zoom-based ER class). Life-threatening acute illness (e.g., infection, heart attack, injury), and no access to a computer, a smartphone or a tablet.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oklahoma Schusterman Center - Tulsa

Tulsa, Oklahoma, 74135, United States

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sophia You, PhD, ABPP

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sophia You, PhD, ABPP

CONTACT

Jordan Keast, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 11, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

April 30, 2030

Last Updated

May 14, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations